An analgesic composition useful for soothing body aches, pains and sores. The analgesic composition can include methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil. Methods for soothing body aches. The methods incl
An analgesic composition useful for soothing body aches, pains and sores. The analgesic composition can include methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil. Methods for soothing body aches. The methods include administering an analgesic composition topically at a location of a body ache.
대표청구항▼
1. A topical analgesic composition comprising 2%-6% methyl salicylate, 2%-6% camphor oil, 2%-6% turpentine oil, 2%-6% sassafras oil, 0.1%-5% oleoresin capsicum, 0.05%-1% chlorophyllin, and 0.1%-5% emu oil, wherein all percentages are by weight, based on the total weight of the composition. 2. The to
1. A topical analgesic composition comprising 2%-6% methyl salicylate, 2%-6% camphor oil, 2%-6% turpentine oil, 2%-6% sassafras oil, 0.1%-5% oleoresin capsicum, 0.05%-1% chlorophyllin, and 0.1%-5% emu oil, wherein all percentages are by weight, based on the total weight of the composition. 2. The topical analgesic composition according to claim 1, further comprising 0.01%-0.1% mustard oil, and 2%-6% beta carotene. 3. The topical composition of claim 1, further comprising a pharmaceutically acceptable carrier. 4. The topical analgesic composition according to claim 3, wherein the carrier comprises white petrolatum and/or medium wax. 5. The topical analgesic composition according to claim 4, wherein the carrier comprises 2%-6% medium wax, and 60%-80% white petrolatum. 6. The topical analgesic composition of claim 3, wherein the pharmaceutically acceptable carrier comprises polysorbate, glycerin, oloxamer 188, alcohol, and/or water. 7. The topical analgesic composition according to claim 1 comprising 4.75% methyl salicylate, 4.75% camphor oil, 4.75% turpentine oil, 4.75% sassafras oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, and 1% emu oil. 8. The topical analgesic composition according to claim 7 further comprising 0.03% mustard oil, and 4.75% beta carotene. 9. The topical analgesic composition according to claim 8, further comprising 4.79% medium wax, and 69.54% white petrolatum. 10. A topical analgesic composition according to claim 1, consisting of 4.75% methyl salicylate, 4.75% turpentine oil, 4.75% camphor oil, 4.75% sassafras oil, 4.75% beta carotene, 1% emu oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, 0.03% mustard oil, 4.79% medium wax, and 69.54% white petrolatum. 11. A topical analgesic composition according to claim 1, consisting of 4.75% methyl salicylate, 4.75% turpentine oil, 4.75% menthol, 4.75% sassafras oil, 4.75% beta carotene, 1% emu oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, 0.03% mustard oil, 4.79% medium wax, and 69.54% white petrolatum. 12. A topical analgesic composition according to claim 1, consisting of 4.75% methyl salicylate, 4.75% turpentine oil, 4.75% sassafras oil, 4.75% beta carotene, 2.375% camphor oil, 2.375 menthol, 1% emu oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, 0.03% mustard oil, 4.79% medium wax, and 69.54% white petrolatum. 13. A method for soothing body aches comprising administering an analgesic composition topically at a location of a body ache to a subject in need thereof, wherein the subject experiences the body ache or anticipates a development of body ache, wherein the analgesic composition is a topical composition according to claim 1. 14. A method according to claim 13, wherein the analgesic composition consists of methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, mustard oil, medium wax, and white petrolatum. 15. A method according to claim 13, wherein the analgesic composition consists of 4.75% methyl salicylate, 4.75% turpentine oil, 4.75% camphor oil, 4.75% sassafras oil, 4.75% beta carotene, 1% emu oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, 0.03% mustard oil, 4.79% medium wax, and 69.54% white petrolatum. 16. The method according to claim 13, wherein the subject has engaged in strenuous physical activity or is about to engage in strenuous activity. 17. The method according to claim 16, wherein the strenuous activity is weight lifting or participation in sports. 18. A therapeutic composition comprising 10%-45% active ingredients, and 55%-90% of pharmaceutical carriers, wherein the active ingredients comprise methyl salicylate, turpentine oil, camphor oil, menthol, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil. 19. The therapeutic composition according to claim 18, wherein the concentrations of the active ingredients are 2%-6% methyl salicylate, 2%-6% turpentine oil, 2%-6% camphor oil, 2%-6% menthol, 2%-6% sassafras oil, 2%-6% beta carotene, 0.05%-2% emu oil, 0.1%-2% oleoresin capsicum, 0.05%-1% chlorophyllin, and 0.01%-1% mustard oil. 20. The therapeutic composition according to claim 18, wherein the pharmaceutical carriers comprise 50%-85% white petrolatum and 2%-6% medium wax. 21. The therapeutic composition according to claim 18, wherein the pharmaceutical carriers are selected from the group consisting of polysorbate 80, glycerin, poloxamer 188, SD alcohol 40-B, water, and mixtures thereof. 22. An analgesic composition according to claim 18, consisting of 4.75% methyl salicylate, 4.75% turpentine oil, 4.75% camphor oil, 4.75% sassafras oil , 4.75% beta carotene, 1% emu oil, 0.59% oleoresin capsicum, 0.3% chlorophyllin, 0.03% mustard oil, 5% polysorbate 80, 20% glycerin, 20% poloxamer 188, 15% S SD alcohol 40-B, and 14.33% water. 23. An analgesic composition comprising methyl salicylate, turpentine oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, and at least one of camphor oil and menthol. 24. The analgesic composition according to claim 23, further comprising chlorophyllin and/or mustard oil.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.